
BeiGene Showcases TEVIMBRA® Data in Lung and GI Cancers at ESMO 2024
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, announced it will present new data on TEVIMBRA® (tislelizumab) at the European Society of Medical Oncology 2024 Congress…












